• INSIGHTEC, an Israeli medical device company specializing in non-invasive
treatment of brain conditions using MR - guided
focused ultrasound, raised $ 150 million in Series E funding.
The Cancer Research Institute (CRI) and the
Focused Ultrasound Foundation (FUSF) established a partnership in 2017 with the goal of advancing the development of new focused ultrasound (FUS) and cancer immunotherapy trea
Focused Ultrasound Foundation (FUSF) established a partnership in 2017 with the goal of advancing the development of new focused ultrasound (FUS) and cancer immunotherapy t
Ultrasound Foundation (FUSF) established a partnership in 2017 with the goal of advancing the development of new
focused ultrasound (FUS) and cancer immunotherapy trea
focused ultrasound (FUS) and cancer immunotherapy t
ultrasound (FUS) and cancer immunotherapy
treatments.